July PBAC marked by firsts

It's the first time PBAC will consider resubmissions through the early re-entry pathway as well as reviews of positive recommendations not accepted by applicants or "use it or lose it" reviews, slightly bumping up the workload for the committee at its meeting this week.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here